These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32211091)

  • 1. A promising independent prognostic biomarker in colorectal cancer: P2X7 receptor.
    Calik I; Calik M; Turken G; Ozercan IH
    Int J Clin Exp Pathol; 2020; 13(2):107-121. PubMed ID: 32211091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P2X7 receptor as an independent prognostic indicator in gastric cancer.
    Calik I; Calik M; Sarikaya B; Ozercan IH; Arslan R; Artas G; Dagli AF
    Bosn J Basic Med Sci; 2020 May; 20(2):188-196. PubMed ID: 32070268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of P2X7R is an independent postoperative indicator of poor prognosis in colorectal cancer.
    Qian F; Xiao J; Hu B; Sun N; Yin W; Zhu J
    Hum Pathol; 2017 Jun; 64():61-68. PubMed ID: 28412208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of P2X7 receptor in prognosis and metastasis of colorectal cancer.
    Zhang Y; Ding J; Wang L
    Adv Med Sci; 2019 Sep; 64(2):388-394. PubMed ID: 31276917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLUT-1 overexpression as an unfavorable prognostic biomarker in patients with colorectal cancer.
    Yang J; Wen J; Tian T; Lu Z; Wang Y; Wang Z; Wang X; Yang Y
    Oncotarget; 2017 Feb; 8(7):11788-11796. PubMed ID: 28052033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in the relationship between P2X7R and colorectal cancer.
    Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
    Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.
    Muratori L; Petroni G; Antonuzzo L; Boni L; Iorio J; Lastraioli E; Bartoli G; Messerini L; Di Costanzo F; Arcangeli A
    Onco Targets Ther; 2016; 9():6325-6332. PubMed ID: 27789963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
    Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
    BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of SLC17A9 correlates with poor prognosis in colorectal cancer.
    Yang L; Chen Z; Xiong W; Ren H; Zhai E; Xu K; Yang H; Zhang Z; Ding L; He Y; Song X; Liu J
    Hum Pathol; 2019 Feb; 84():62-70. PubMed ID: 30236596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokineticin 2 expression as a novel prognostic biomarker for human colorectal cancer.
    Yoshida Y; Goi T; Kurebayashi H; Morikawa M; Hirono Y; Katayama K
    Oncotarget; 2018 Jul; 9(53):30079-30091. PubMed ID: 30046389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.
    GabAllah GMK; El-Din Habib MS; Soliman SE; Kasemy ZA; Gohar SF
    Saudi J Gastroenterol; 2017; 23(6):348-356. PubMed ID: 29205188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. hERG1 Channels and Glut-1 as Independent Prognostic Indicators of Worse Outcome in Stage I and II Colorectal Cancer: A Pilot Study.
    Lastraioli E; Bencini L; Bianchini E; Romoli MR; Crociani O; Giommoni E; Messerini L; Gasperoni S; Moretti R; Di Costanzo F; Boni L; Arcangeli A
    Transl Oncol; 2012 Apr; 5(2):105-12. PubMed ID: 22496927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
    Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
    Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of DHRS9 expression in colorectal cancer tissues and its prognostic significance.
    Hu L; Chen HY; Han T; Yang GZ; Feng D; Qi CY; Gong H; Zhai YX; Cai QP; Gao CF
    Tumour Biol; 2016 Jan; 37(1):837-45. PubMed ID: 26254099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological Characterization and Prognostic Implication of SMAD4 Expression in Colorectal Carcinoma.
    Yoo SY; Lee JA; Shin Y; Cho NY; Bae JM; Kang GH
    J Pathol Transl Med; 2019 Sep; 53(5):289-297. PubMed ID: 31237997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GADD45B as a Prognostic and Predictive Biomarker in Stage II Colorectal Cancer.
    Zhao Z; Gao Y; Guan X; Liu Z; Jiang Z; Liu X; Lin H; Yang M; Li C; Yang R; Zou S; Wang X
    Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30029519
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer.
    Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells.
    Giannuzzo A; Pedersen SF; Novak I
    Mol Cancer; 2015 Nov; 14():203. PubMed ID: 26607222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
    Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
    Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.